Christian Hölscher
School of Biomedical Sciences
Ulster University
Coleraine
UK
Name/email consistency: high
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. Hunter, K., Hölscher, C. BMC. Neurosci (2012)
- Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. Faivre, E., Gault, V.A., Thorens, B., Hölscher, C. J. Neurophysiol. (2011)
- Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease. Holscher, C. Recent. Pat. CNS. Drug. Discov (2010)
- Anaesthesia generates neuronal insulin resistance by inducing hypothermia. Holscher, C., van Aalten, L., Sutherland, C. BMC. Neurosci (2008)
- Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Holscher, C., Gengler, S., Gault, V.A., Harriott, P., Mallot, H.A. Eur. J. Pharmacol. (2007)
- Lack of the metabotropic glutamate receptor subtype 7 selectively modulates Theta rhythm and working memory. Hölscher, C., Schmid, S., Pilz, P.K., Sansig, G., van der Putten, H., Plappert, C.F. Learn. Mem. (2005)
- Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Hölscher, C. Rev. Neurosci (2005)